Alterity Therapeutics (ATHE) said on Monday it appointed Abby Niven to succeed Phillip Hains as chief financial officer, effective today.
Niven has extensive experience in private wealth management with groups including ANZ, UBS and Ord Minett and consults on governance, finance, and corporate structure for various companies.
Hains continues as company secretary.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments